PILO SHLOMO (Chief Executive Officer) received a stock award from RAPHAEL PHARMACEUTICAL INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/11/2025ACC: 0001213900-25-022736
DirectorOfficer10% Owner· Chief Executive Officer
Since Sep 2021
+300K
Net shares
Net buyer
$100.0K
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
300K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+200K
Price / share
$0.50
Trade value
$100K
% of position
5.3%
3/2/2025
3.78M→3.98M
Total
Net shares
+200K
Net value
$100K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2025 | A · Award | +200K | $0.50 | $100K | 5.3% | 3.78M | 3.98M |
| Total | +200K | $100K | ||||||
Derivative Transactions1
Warrant to purchase Common Stock
Direct
Converts to
Common Stock
100K shares
Shares
+100K
Strike price
1.00
Held after
1.10M
Exercisable
—
3/2/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrant to purchase Common Stock Direct | Common Stock100K shares | 3/2/2025 | A · Award | +100K | 1.00 | — | 1.10M |